Status:
COMPLETED
Optimal Timing of Dinoprostone Administration Prior to Office Hysteroscopy
Lead Sponsor:
Cairo University
Conditions:
Dinoprostone Timing
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
The aim of this study is to determine whether dinoprostone administered 10 hours before office hysteroscopy can relieve pain more effectively compared with dinoprostone administered 3 hours before off...
Eligibility Criteria
Inclusion
- Nulliparous patients who have an indication for office hysteroscopy
Exclusion
- Parous patients, menopausal patients and patients with cervical pathology, and previous cervical surgery will be excluded from the study. Moreover, patients with severe vaginal bleeding, allergy to dinoprostone
Key Trial Info
Start Date :
September 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04085757
Start Date
September 15 2019
End Date
January 1 2020
Last Update
May 7 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of medicine Cairo university
Giza, Egypt, 11231
2
Tertiary referral hospital
Giza, Egypt